Back China Strategy

China: Beijing Unlikely to Take Decisive Action on Overcapacity Soon

Published on July 10, 2025

∙ Download the PDF Report

By

Michael Hirson

Houze Song

SUMMARY

  • China’s leadership has not signaled the level of resolve necessary to tackle overcapacity at the macro level; in addition to stronger action forcing local governments to curb capacity growth, Beijing will also need to implement demand-side stimulus.
  • At the same time, we are cautiously optimistic that a more decisive policy pivot on overcapacity will come in the next several quarters, driven by the urgency of the problem; industrial weakness will pose a growing threat to the financial system, forcing the central government to act.
  • Signposts of a more serious effort would include explicit references to overcapacity and concrete steps such as production cuts; the release of the 15th Five-Year Plan (2026–2030) in October/November and the Central Economic Work Conference in December may provide clearer signals as to whether policy is shifting.

Speculation that China’s central government will take more aggressive action to combat overcapacity and deflation has spiked since a high-level meeting on July 1. A meeting of the Central Financial and Economic Commission (CFEC), chaired by Xi, pledged to “govern low-price and disorderly competition among enterprises.” This has been followed by additional commentary in the state media and a Ministry of Industry and Information Technology meeting on solar industry.

Beijing’s level of concern over industrial “involution” – meant to describe industries engaged in self-destructive cycles of capacity expansion – is clearly rising, and this will be a key watchpoint in coming months.

However, we remain unconvinced that policy has reached a true inflection point. Addressing the overcapacity issue at the macro level, across industries, would require not only strong political will but also a broader shift in macroeconomic policy, including not only supply cuts but also more aggressive demand-side stimulus. We are growing cautiously optimistic that Beijing will be forced to make a more decisive pivot in 2026, leading to progress over the next 12 months. But that remains speculative for now, and we see little chance of significant progress in the next three months.

Concerted Action is Necessary

Any discussion of “involution” needs to acknowledge the core political economy issue. The political and economic support for companies to expand production, even at the expense of crushing profit margins, comes from local governments who rely on these firms for tax revenues and employment. Local officials support their hometown firms by leaning on local banks to extend loans and by arranging other forms of economic support.

The upshot is that any crackdown on overcapacity requires China’s leadership to exert aggressive top-down political pressure on local governments, and at times directly on firms and financial institutions.

With this backdrop, our skepticism regarding Beijing’s determination is based on the following three considerations:

First, recent developments suggest that consolidation efforts remain largely voluntary, with no indication of government-mandated cuts. Notably, just a month ago, Beijing abandoned a planned merger between two central state-owned automakers, Changan Auto and Dongfeng Auto — both of which have struggled in the transition to EVs. We view this as clear evidence that Beijing is not prepared to pursue consolidation through administrative means. If the government is unwilling to force consolidation among state-owned enterprises, it is even less likely to strongly push for consolidation among private firms—many of which dominate overcapacity sectors such as solar and batteries. This is a key difference with China’s successful capacity cuts in 2016-2017, which involved SOE-dominated sectors such as steel and coal.

Moreover, the scale of overcapacity is such that mergers and acquisitions alone are unlikely to suffice. For example, China’s polysilicon production capacity is more than twice global demand. Even if Beijing successfully engineered a merger, industry utilization would remain below 50%. Such sectors will need to see capacity reduction and market exit of struggling firms, a challenge for local governments and an undeveloped corporate bankruptcy system.

Second, we believe intense domestic competition and low prices are essential to Beijing’s overarching goal of making China a global manufacturing superpower. In other words, global market share matters more to Beijing than profits. As a result, we expect government intervention only when market competition begins to cause clearly damaging outcomes. One recent example is the government’s move to require automakers to pay suppliers within 90 days—a shift from previous norms where payments were often delayed more than 200 days, placing significant financial strain on suppliers and weakening their R&D capacity. In our view, such measures may limit further downside in overcapacity sectors but are unlikely to create meaningful upside.

Demand-side Support Missing

Third, the current weak macroeconomic backdrop is also unfavorable for resolving overcapacity. Only a combination of supply-side reform and stronger demand-side support would produce a meaningful reduction in overcapacity. However, as detailed in our recent H2 2025 outlook (link HERE], we are skeptical that Beijing is committed to aggressive stimulus in coming months. Thus far, the policy signals are consistent with the leadership continuing to focus more on controlling debt risk (meaning weak local government investment), rather than stimulating growth.

A weak economy also reduces Beijing’s willingness and ability to absorb the pain associated with aggressive supply-side cuts. These cuts would weigh on already-stretched local government finances, which are suffering from declining land sales revenue and mounting debt repayment burdens. As such, we believe a growth bottoming is a necessary precondition for any serious effort to tackle overcapacity.

Cautiously Optimistic about Future Steps

While our near-term expectations remain low, we see reasons to be more optimistic over the medium term (6–12 months). The necessary conditions for action are already in place: China has been in deflation for three years — the longest stretch since 1978 — with industrial sectors bearing the brunt. The risk that industrial distress evolves into broader banking stress is already elevated and rising. In our view, mounting debt risks are the most likely catalyst for more forceful action on overcapacity. We expect both exports and domestic demand to weaken further in the coming months, while sectors like solar and EVs face added pressure from expiring incentives. As a result, we believe Beijing may have little choice but to address overcapacity more decisively in the quarters ahead to mitigate financial risk.

So far, Beijing has focused primarily on mitigating the symptoms of overcapacity — such as price wars — which are, at best, temporary fixes. For more decisive action to materialize, we would need to see more explicit references to overcapacity and concrete steps such as production cuts. Two key events in the second half — the release of the 15th Five-Year Plan (2026–2030) in October/November and the Central Economic Work Conference in December — may provide clearer signals on whether Beijing intends to take overcapacity more seriously.

DISCLOSURES AND DISCLAIMERS

Analyst Certification

The analyst, 22V Research Group, primarily responsible for the preparation of this research report attests to the following: (1) that the views and opinions rendered in this research report reflect his or her personal views about the subject companies or issuers; and (2) that no part of the research analyst’s compensation was, is, or will be directly related to the specific recommendations or views in this research report.

Analyst Certifications and Independence of Research.

Each of the 22V Research analysts whose names appear on the front page of this report hereby certify that all the views expressed in this Report accurately reflect our personal views about any and all of the subject securities or issuers and that no part of our compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views of in this Report.

22V Research (the “Company”) is an independent research provider. The Company is not a member of the FINRA or the SIPC and is not a registered broker dealer or investment adviser. 22V Research has no other regulated or unregulated business activities which conflict with its provision of independent research.

22V Research, LLC is a professional services and independent publication organization. 22V Research, LLC is not a securities broker-dealer, not a member of the Financial Industry Regulatory Authority (FINRA), not a registered investment advisor (RIA) and not a member of SIPC.

Securities transactions, when offered, are offered by 22V Securities, LLC through LPS Capital, LLC. Certain employees of 22V Securities, LLC are dually registered as securities representatives of LPS Capital, LLC or Analyst Hub Securities, LLC. 22V Securities, LPS Capital and Analyst Hub Securities are members FINRA, SIPC.

https://brokercheck.finra.org/

Current Ratings Definition.

SECTOR OUTPERFORM: An “outperform” rating anticipates the company will outperform the S&P Regional Banking Index (peer group).

SECTOR PERFORM: A “market perform” rating anticipates the company will perform in line with the S&P Regional Banking Index (peer group).

SECTOR UNDERPERFORM: An “underperform” rating anticipates the company will underperform the S&P Regional Banking Index (peer group).

Limitation Of Research And Information.

This Report has been prepared for distribution to only qualified institutional or professional clients of 22V Research Group. The contents of this Report represent the views, opinions, and analyses of its authors. The information contained herein does not constitute financial, legal, tax or any other advice. All third-party data presented herein were obtained from publicly available sources which are believed to be reliable; however, the Company makes no warranty, express or implied, concerning the accuracy or completeness of such information. In no event shall the Company be responsible or liable for the correctness of, or update to, any such material or for any damage or lost opportunities resulting from use of this data. Nothing contained in this Report or any distribution by the Company should be construed as any offer to sell, or any solicitation of an offer to buy, any security or investment. Any research or other material received should not be construed as individualized investment advice. Investment decisions should be made as part of an overall portfolio strategy and you should consult with a professional financial advisor, legal and tax advisor prior to making any investment decision. 22V Research Group shall not be liable for any direct or indirect, incidental or consequential loss or damage (including loss of profits, revenue or goodwill) arising from any investment decisions based on information or research obtained from 22V Research Group.

Reproduction And Distribution Strictly Prohibited.

No user of this Report may reproduce, modify, copy, distribute, sell, resell, transmit, transfer, license, assign or publish the Report itself or any information contained therein. Notwithstanding the foregoing, clients with access to working models are permitted to alter or modify the information contained therein, provided that it is solely for such client’s own use. This Report is not intended to be available or distributed for any purpose that would be deemed unlawful or otherwise prohibited by any local, state, national or international laws or regulations or would otherwise subject the Company to registration or regulation of any kind within such jurisdiction.

Copyrights, Trademarks, Intellectual Property.

22V Research Group, and any logos or marks included in this Report are proprietary materials. The use of such terms and logos and marks without the express written consent of 22V Research Group is strictly prohibited. The copyright in the pages or in the screens of the Report, and in the information and material therein, is proprietary material owned by 22V Research Group unless otherwise indicated. The unauthorized use of any material on this Report may violate numerous statutes, regulations and laws, including, but not limited to, copyright, trademark, trade secret or patent laws.